At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Muscarinic M1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Irritable bowel syndrome
Most Recent Events
- 03 Nov 1998 No-Development-Reported for Irritable bowel syndrome in Italy (Unknown route)
- 21 Jun 1996 Preclinical development for Irritable bowel syndrome in Italy (Unknown route)
- 20 Jun 1996 New profile